Western Standard LLC’s Neurogene NGNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-43,044	Closed	-$715K	–	32
2023 Q2	$715K	Buy	+43,044	New	+$715K	0.62%	24